CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,062,407

+$2,037,211 QoQ

Shares Held

521,216

+17.4% QoQ

Ownership

0.590%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 224 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. MLYS ranks #90 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,062,407	521,216	+17.4%	Shares	Sole	2026-08-14
2026-03-31	$12,025,196	443,898	-3.8%	Shares	Sole	2026-05-15
2025-12-31	$16,740,577	461,300	+12.7%	Shares	Sole	2026-02-13
2025-09-30	$15,516,371	409,187	+26.2%	Shares	Sole	2025-11-10
2025-06-30	$4,386,493	324,205	+50.9%	Shares	Sole	2025-08-12
2024-12-31	$2,645,492	214,906	+0.6%	Shares	Sole	2025-02-06
2024-09-30	$2,586,683	213,599	+4.7%	Shares	Sole	2024-11-12
2024-06-30	$2,386,039	203,935	+68.7%	Shares	Sole	2024-08-12
2024-03-31	$1,560,328	120,862	-0.0%	Shares	Sole	2024-05-09
2023-12-31	$1,039,499	120,872	+13.6%	Shares	Sole	2024-02-06
2023-09-30	$1,011,921	106,406	+11.2%	Shares	Sole	2023-11-08
2023-06-30	$1,631,531	95,691	+7.6%	Shares	Sole	2023-08-10
2023-03-31	$1,393,113	88,960	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.